Figure 2.
Summary of the BEYOND trial.28,36,37,39 EMH, extramedullary hematopoiesis; T/W, tiredness/weakness.

Summary of the BEYOND trial.28,36,37,39 EMH, extramedullary hematopoiesis; T/W, tiredness/weakness.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal